RxDoctor Payments Data

Kristen Marquis

Psychiatric/Mental Health · Albany, NYNPI 1487384657

Payments from drug & device makers

$6,626in general payments, 2019–2025

Across 323 payments — averaging $20.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Axsome Therapeutics, Inc.$624
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$554
  • Neurocrine Biosciences, Inc.$526
  • Johnson & Johnson$512
  • Corium, LLC$493
  • plus $3K from 15 others

What the payments were for

  • Food & beverage$6,626100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,626 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl19$26,444
VyvanseLisdexamfetamine Dimesylate15$5,653
Aripiprazole84$3,578
Duloxetine Hcl81$1,366
Venlafaxine Hcl ErVenlafaxine Hcl14$870
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$860
Clonazepam100$557
Sertraline Hcl50$483
Gabapentin19$482
Mirtazapine26$477
Hydroxyzine Pamoate25$391
Buspirone Hcl13$372
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$349
Divalproex Sodium ErDivalproex Sodium21$331
Quetiapine Fumarate20$308

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,244$26,44419 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$369$5,65315 claims
Lilly USA, LLCOlanzapine$51$18615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →